Protocol Name: Vonafexor Fixed Dose-escalation Safety and Proof-of-concept Study in Patients With at Risk of Progression Alport Syndrome
Sponsor: Enyo Pharma
Indication: Alport Syndrome
Principal Investigator: Ankit Mehta, MD
Location: Dallas Transplant Institute, 3604 Live Oak Street, Suite 100, Dallas, TX 75204